BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27297279)

  • 1. Livedoid vasculopathy: A review of pathogenesis and principles of management.
    Vasudevan B; Neema S; Verma R
    Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.
    Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
    J Am Acad Dermatol; 2013 Dec; 69(6):1033-1042.e1. PubMed ID: 24028907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy - a thrombotic disease.
    Kerk N; Goerge T
    Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
    Reagin H; Marks E; Weis S; Susa J
    Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of livedoid vasculopathy in a 22-year-old man.
    Leonard A; Pomeranz MK; Franks AG
    J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
    Meiss F; Marsch WC; Fischer M
    Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
    Burg MR; Mitschang C; Goerge T; Schneider SW
    Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
    Seguí M; Llamas-Velasco M
    Front Med (Lausanne); 2022; 9():993515. PubMed ID: 36569162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of widespread livedoid vasculopathy with pain but no systemic symptoms.
    Okada E; Nagai Y; Ishikawa O
    Acta Derm Venereol; 2008; 88(3):298-9. PubMed ID: 18480943
    [No Abstract]   [Full Text] [Related]  

  • 18. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.